Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-32 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-32 |
filingDate |
1999-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2001-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c2a0a5f4e519a5ba53d06ee27ad6e7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a5bb722e125a9a6deee2cccc7cdc3c5 |
publicationDate |
2001-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6177564-B1 |
titleOfInvention |
Process for the synthesis of N-benzyl-3-(4-fluorophenyl)-1-4-oxazin-2-one |
abstract |
The present invention is concerned with a novel process for the preparation of N-benzyl-3-(4-fluorophenyl)-1,4-oxazin-2-one of the formula:This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity, in particular, as substance P (neurokinin-1) receptor antagonists. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102898396-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133994-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102898396-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011094321-A1 |
priorityDate |
1998-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |